Results

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	RMSD	Seq. Identity (%)	HETATM
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1AJ6_A_NOVA1_1 (GYRASE)	1q2w	3C-LIKE PROTEASE (SARSr-CoV)	5 / 9	ASN A 238 GLU A 240 ILE A 200 ALA A 129 THR A 201	1.77A	20.25	None MPD A 307 (-3.9A) MPD A 307 (-4.4A) None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_C_NOVC2000_1 (DNA GYRASE SUBUNIT B)	1uk2	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	GLU B 288 ASP B 289 ILE B 286 ILE A 286 SER A 284	1.43A	23.45	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_D_NOVD2000_1 (DNA GYRASE SUBUNIT B)	1uk2	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	GLU B 288 ASP B 289 ILE B 286 ILE A 286 SER A 284	1.38A	23.45	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_A_NOVA2000_1 (DNA GYRASE SUBUNIT B)	1uk2	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	GLU B 288 ASP B 289 ILE B 286 ILE A 286 SER A 284	1.40A	23.45	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_A_NOVA2000_1 (DNA GYRASE SUBUNIT B)	1wnc	E2 GLYCOPROTEIN (SARSr-CoV)	5 / 12	GLU D 918 ILE D 916 GLN F 915 ILE F 916 SER E 919	1.54A	20.78	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_B_NOVB403_1 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	1wnc	E2 GLYCOPROTEIN (SARSr-CoV)	4 / 7	PHE B 909 ALA A 912 GLN A 915 GLN C 902	1.22A	19.58	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_B_NOVB403_1 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	1x7q	HLA, A-11 (Homo sapiens)	4 / 7	PHE A 36 ARG A 35 GLN A 72 GLN A 32	1.17A	22.48	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_2 (DNA GYRASE SUBUNIT B)	1x7q	BETA-2-MICROGLOBULIN HLA, A-11 (Homo sapiens)	3 / 3	ASP A 119 PHE B 62 VAL A 12	1.19A	21.59	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_A_NOVA403_2 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	1z1i	3C-LIKE PROTEINASE (SARSr-CoV)	4 / 6	PHE A 3 ARG A 4 LEU A 282 ALA A 210	1.29A	22.53	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_B_NOVB403_1 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	1z1i	3C-LIKE PROTEINASE (SARSr-CoV)	4 / 7	PHE A 3 ARG A 4 LEU A 282 ALA A 210	1.31A	22.53	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1AJ6_A_NOVA1_1 (GYRASE)	1z1j	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 9	ASN B1238 GLU B1240 ILE B1200 ALA B1129 THR B1201	1.49A	20.00	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_1 (DNA GYRASE SUBUNIT B)	1z1j	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	ASN A 203 GLU A 290 ARG B1004 ALA A 206 THR A 111	1.76A	22.61	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_C_NOVC2000_1 (DNA GYRASE SUBUNIT B)	1zv8	E2 GLYCOPROTEIN (SARSr-CoV)	5 / 12	ILE E 16 GLN C 15 ALA C 12 ILE C 16 SER A 19	1.52A	13.24	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_B_NOVB403_1 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	1zv8	E2 GLYCOPROTEIN (SARSr-CoV)	4 / 7	PHE A 9 ALA E 12 GLN E 15 GLN C 2	1.16A	9.50	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_1 (DNA GYRASE SUBUNIT B)	1zva	E2 GLYCOPROTEIN (SARSr-CoV)	5 / 12	ASN A 54 ILE A 30 ASP A 36 ILE A 48 ALA A 50	1.77A	13.54	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1S14_B_NOVB2300_1 (TOPOISOMERASE IV SUBUNIT B)	1zvb	E2 GLYCOPROTEIN (SARSr-CoV)	5 / 12	ASN B 21 SER B 25 ASP B 22 ASP B 28 ALA A 15	1.72A	11.68	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_D_NOVD2000_1 (DNA GYRASE SUBUNIT B)	1zvb	E2 GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER A 17 ILE A 23 ASP B 28 ILE B 23 ARG A 26	1.60A	7.86	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_A_NOVA2000_1 (DNA GYRASE SUBUNIT B)	1zvb	E2 GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER A 17 ILE A 23 ASP B 28 ILE B 23 ARG A 26	1.60A	7.86	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_A_NOVA403_1 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	2a5k	3C-LIKE PEPTIDASE (SARSr-CoV)	5 / 10	HIS B 164 ALA B 173 GLU B 47 VAL B 186 ARG B 188	1.71A	23.12	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_A_NOVA403_2 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	2a5k	3C-LIKE PEPTIDASE (SARSr-CoV)	4 / 6	PHE B 3 ARG B 4 LEU B 282 ALA B 210	1.42A	23.12	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_C_NOVC2000_1 (DNA GYRASE SUBUNIT B)	2acf	REPLICASE POLYPROTEIN 1AB (SARS-COV Tor2)	5 / 12	ASN D 219 ILE D 217 GLN D 210 ALA D 209 ILE D 205	1.74A	22.40	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_A_NOVA403_2 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	2acf	REPLICASE POLYPROTEIN 1AB (SARS-COV Tor2)	4 / 6	PHE B 314 LEU B 309 ALA B 220 GLN B 320	1.41A	21.97	GOL B1004 (-4.5A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_C_NOVC2000_1 (DNA GYRASE SUBUNIT B)	2ahm	REPLICASE POLYPROTEIN 1AB, HEAVY CHAIN (SARSr-CoV)	5 / 12	ASN F 105 ILE F 112 ASP F 117 ILE F 111 ARG F 116	1.75A	19.52	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_A_NOVA2000_1 (DNA GYRASE SUBUNIT B)	2ahm	REPLICASE POLYPROTEIN 1AB, HEAVY CHAIN (SARSr-CoV)	5 / 12	ASN F 105 ILE F 112 ASP F 117 ILE F 111 ARG F 116	1.77A	19.52	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_1 (DNA GYRASE SUBUNIT B)	2ahm	REPLICASE POLYPROTEIN 1AB, HEAVY CHAIN (SARSr-CoV)	5 / 12	ASN H 105 ILE H 112 ASP H 117 ILE H 111 ARG H 116	1.68A	18.02	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1AJ6_A_NOVA1_1 (GYRASE)	2ahm	REPLICASE POLYPROTEIN 1AB, HEAVY CHAIN (SARSr-CoV)	5 / 9	ASN E 105 ASP E 104 ILE E 112 ALA E 115 ILE E 111	1.60A	18.99	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_A_NOVA400_1 (DNA GYRASE SUBUNIT B)	2ahm	REPLICASE POLYPROTEIN 1AB, HEAVY CHAIN (SARSr-CoV)	5 / 12	ASP H 104 ILE H 112 ASP H 117 ILE H 111 ARG H 116	1.54A	18.02	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_D_NOVD2000_1 (DNA GYRASE SUBUNIT B)	2ahm	REPLICASE POLYPROTEIN 1AB, HEAVY CHAIN (SARSr-CoV)	5 / 12	ASN H 105 ASP H 104 ILE H 112 ASP H 117 ILE H 111	1.61A	19.52	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1S14_B_NOVB2300_1 (TOPOISOMERASE IV SUBUNIT B)	2ahm	REPLICASE POLYPROTEIN 1AB, HEAVY CHAIN (SARSr-CoV)	5 / 12	ASN F 105 ASP F 106 ALA F 115 ILE F 111 ARG F 116	1.72A	21.00	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1S14_B_NOVB2300_1 (TOPOISOMERASE IV SUBUNIT B)	2ajf	SPIKE PROTEIN (SARSr-CoV)	5 / 12	SER F 386 ASP F 385 ASP F 351 ALA F 350 ILE F 345	1.53A	21.86	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1S14_B_NOVB2300_1 (TOPOISOMERASE IV SUBUNIT B)	2ajf	ACE2 (Homo sapiens)	5 / 12	ASN A 437 GLU A 435 ASP A 431 PRO A 415 ALA A 413	1.77A	14.86	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_A_NOVA400_2 (DNA GYRASE SUBUNIT B)	2ajf	SPIKE PROTEIN (SARSr-CoV)	3 / 3	ASN F 375 PHE F 325 VAL F 382	1.34A	20.60	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_B_NOVB403_1 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	2ajf	SPIKE PROTEIN (SARSr-CoV)	4 / 7	ARG F 449 LEU F 448 ALA F 406 GLN F 396	1.44A	20.16	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_A_NOVA403_2 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	2alv	REPLICASE POLYPROTEIN 1AB (SARSr-CoV)	4 / 6	PHE A 3 ARG A 4 LEU A 282 ALA A 210	1.52A	21.12	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_A_NOVA403_2 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	2amq	3C-LIKE PROTEINASE (SARSr-CoV)	4 / 6	PHE A 3 ARG A 4 LEU A 282 ALA A 210	1.33A	22.81	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_A_NOVA403_1 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	2amq	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 10	HIS A 164 ALA A 173 GLU A 47 VAL A 186 ARG A 188	1.70A	22.81	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_B_NOVB403_1 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	2amq	3C-LIKE PROTEINASE (SARSr-CoV)	4 / 7	PHE A 3 ARG A 4 LEU A 282 ALA A 210	1.37A	22.81	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_A_NOVA2000_1 (DNA GYRASE SUBUNIT B)	2beq	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	GLU F1177 ILE A 916 ASP F1181 ILE C 916 SER C 919	1.78A	13.46	None None ACE B 913 ( 3.7A) ACE C 913 ( 4.1A) None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_C_NOVC2000_1 (DNA GYRASE SUBUNIT B)	2beq	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	GLU F1177 ILE A 916 ASP F1181 ILE C 916 SER C 919	1.66A	13.46	None None ACE B 913 ( 3.7A) ACE C 913 ( 4.1A) None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_A_NOVA2000_1 (DNA GYRASE SUBUNIT B)	2cjr	NUCLEOCAPSID PROTEIN (SARS-COV TW1)	5 / 12	SER E 313 PRO F 259 ASP E 341 ILE E 338 SER E 319	1.58A	15.74	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_A_NOVA403_2 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	2cjr	NUCLEOCAPSID PROTEIN (SARS-COV TW1)	4 / 6	PHE C 275 ARG C 277 ALA C 265 GLN B 273	1.53A	19.50	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URN_A_NOVA2000_1 (DNA TOPOISOMERASE IV, B SUBUNIT)	2d2d	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 11	ASP A 295 GLU A 290 ASP A 289 ARG B 4 ILE A 106	1.64A	19.87	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_D_NOVD2000_1 (DNA GYRASE SUBUNIT B)	2d2d	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	ILE A 213 ASP A 216 SER A 301 ARG A 217 THR A 257	1.74A	23.66	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1S14_A_NOVA1300_1 (TOPOISOMERASE IV SUBUNIT B)	2dd8	IGG HEAVY CHAIN IGG LIGHT CHAIN (Homo sapiens)	5 / 12	ASN H 58 ASP L 95 ASP H 95 ILE H 56 THR H 33	1.69A	22.69	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_A_NOVA400_2 (DNA GYRASE SUBUNIT B)	2dd8	SPIKE GLYCOPROTEIN (SARSr-CoV)	3 / 3	ASN S 381 PHE S 325 VAL S 510	1.45A	20.30	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1S14_B_NOVB2300_1 (TOPOISOMERASE IV SUBUNIT B)	2dd8	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER S 386 ASP S 385 ASP S 351 ALA S 350 ILE S 345	1.52A	21.28	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LPS_A_NOVA901_1 (TOPOISOMERASE IV SUBUNIT B)	2dd8	IGG HEAVY CHAIN IGG LIGHT CHAIN (Homo sapiens)	5 / 12	ASN H 58 ASP L 95 ASP H 95 ILE H 56 THR H 33	1.73A	17.55	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URN_A_NOVA2000_1 (DNA TOPOISOMERASE IV, B SUBUNIT)	2dd8	IGG HEAVY CHAIN (Homo sapiens)	5 / 11	SER H 74 GLU H 73 ASP H 72 ILE H 53 THR H 71	1.39A	24.31	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_2 (DNA GYRASE SUBUNIT B)	2dd8	SPIKE GLYCOPROTEIN (SARSr-CoV)	3 / 3	ASP S 385 PHE S 416 VAL S 420	1.34A	20.30	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_C_NOVC2000_1 (DNA GYRASE SUBUNIT B)	2fav	REPLICASE POLYPROTEIN 1AB (PP1AB) (ORF1AB) (SARSr-CoV)	5 / 12	ASN B 38 ILE B 36 GLN B 29 ALA B 28 ILE B 24	1.62A	20.33	None None None None APR B 477 (-4.0A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_A_NOVA403_2 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	2fav	REPLICASE POLYPROTEIN 1AB (PP1AB) (ORF1AB) (SARSr-CoV)	4 / 6	PHE C 133 LEU C 128 ALA C 39 GLN C 139	1.31A	20.25	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_1 (DNA GYRASE SUBUNIT B)	2ghw	ANTI-SCFV ANTIBODY, 80R (Homo sapiens)	5 / 12	GLU D 213 PRO D 191 ASP D 192 ILE D 207 TYR D 218	1.42A	20.49	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_2 (DNA GYRASE SUBUNIT B)	2ghw	SPIKE GLYCOPROTEIN (SARSr-CoV)	3 / 3	ASP A 385 PHE A 416 VAL A 420	1.38A	22.28	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_A_NOVA2000_1 (DNA GYRASE SUBUNIT B)	2gri	NSP3 (SARSr)	5 / 12	ASN A 37 GLU A 27 ASP A 29 ILE A 24 SER A 41	1.46A	20.72	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_C_NOVC2000_1 (DNA GYRASE SUBUNIT B)	2h85	PUTATIVE ORF1AB POLYPROTEIN (SARSr-CoV)	5 / 12	ILE A 99 PRO A 111 ALA A 81 ILE A 79 SER A 97	1.68A	21.39	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_A_NOVA403_2 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	2h85	PUTATIVE ORF1AB POLYPROTEIN (SARSr-CoV)	4 / 6	PHE A 213 LEU A 214 ALA A 255 GLN A 208	1.49A	23.44	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_A_NOVA403_1 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	2h85	PUTATIVE ORF1AB POLYPROTEIN (SARSr-CoV)	5 / 10	ALA A 81 PRO A 67 GLU A 68 VAL A 127 ARG A 126	1.56A	23.44	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_D_NOVD2000_1 (DNA GYRASE SUBUNIT B)	2h85	PUTATIVE ORF1AB POLYPROTEIN (SARSr-CoV)	5 / 12	GLU A 113 ILE A 99 PRO A 111 ILE A 79 SER A 97	1.76A	21.39	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_A_NOVA2000_1 (DNA GYRASE SUBUNIT B)	2h85	PUTATIVE ORF1AB POLYPROTEIN (SARSr-CoV)	5 / 12	GLU A 113 ILE A 99 PRO A 111 ILE A 79 SER A 97	1.75A	21.39	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1AJ6_A_NOVA1_1 (GYRASE)	2jw8	NUCLEOCAPSID PROTEIN (SARSr-CoV)	5 / 9	ASN A 350 ASP A 344 PRO A 310 ALA B 312 ILE A 305	1.67A	18.47	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1AJ6_A_NOVA1_1 (GYRASE)	2jzf	REPLICASE POLYPROTEIN 1AB (SARSr-CoV)	5 / 9	ASP A 552 PRO A 588 ALA A 590 ILE A 592 THR A 612	1.50A	20.81	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_1 (DNA GYRASE SUBUNIT B)	2kqv	NSP3 (SARSr-CoV)	5 / 12	ARG A 32 ILE A 38 ILE A 45 TYR A 42 THR A 37	1.74A	19.23	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1AJ6_A_NOVA1_1 (GYRASE)	2kqv	NSP3 (SARSr-CoV)	5 / 9	ASP A 30 PRO A 66 ALA A 68 ILE A 70 THR A 90	1.38A	20.60	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1AJ6_A_NOVA1_1 (GYRASE)	2op9	REPLICASE POLYPROTEIN 1AB (PP1AB, ORF1AB) 3C-LIKE PROTEINASE (3CL-PRO, 3CLP) (SARSr-CoV)	5 / 9	ASN A 238 GLU A 240 ILE A 200 ALA A 129 THR A 201	1.80A	20.13	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_A_NOVA403_2 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	2op9	REPLICASE POLYPROTEIN 1AB (PP1AB, ORF1AB) 3C-LIKE PROTEINASE (3CL-PRO, 3CLP) (SARSr-CoV)	4 / 6	PHE B 3 ARG B 4 LEU B 282 ALA B 210	1.50A	21.73	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_A_NOVA403_1 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	2ozk	URIDYLATE-SPECIFIC ENDORIBONUCLEASE (SARSr-CoV)	5 / 10	ALA C 81 PRO C 67 GLU C 68 VAL C 127 ARG C 126	1.59A	23.44	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1AJ6_A_NOVA1_1 (GYRASE)	2ozk	URIDYLATE-SPECIFIC ENDORIBONUCLEASE (SARSr-CoV)	5 / 9	GLU D 113 ILE D 99 PRO D 111 ALA D 81 ILE D 79	1.75A	22.51	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_A_NOVA2000_1 (DNA GYRASE SUBUNIT B)	2ozk	URIDYLATE-SPECIFIC ENDORIBONUCLEASE (SARSr-CoV)	5 / 12	GLU A 113 ILE A 99 PRO A 111 ILE A 79 SER A 97	1.67A	21.51	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_A_NOVA403_2 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	2ozk	URIDYLATE-SPECIFIC ENDORIBONUCLEASE (SARSr-CoV)	4 / 6	PHE B 213 LEU B 214 ALA B 255 GLN B 208	1.47A	23.44	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_C_NOVC2000_1 (DNA GYRASE SUBUNIT B)	2ozk	URIDYLATE-SPECIFIC ENDORIBONUCLEASE (SARSr-CoV)	5 / 12	ILE C 99 PRO C 111 ALA C 81 ILE C 79 SER C 97	1.61A	21.51	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_D_NOVD2000_1 (DNA GYRASE SUBUNIT B)	2ozk	URIDYLATE-SPECIFIC ENDORIBONUCLEASE (SARSr-CoV)	5 / 12	GLU A 113 ILE A 99 PRO A 111 ILE A 79 SER A 97	1.69A	21.51	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_A_NOVA403_2 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	2q6g	REPLICASE POLYPROTEIN 1AB (SARS-COV BJ01)	4 / 6	PHE A 3 ARG A 4 LEU A 282 ALA A 210	1.43A	22.53	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1AJ6_A_NOVA1_1 (GYRASE)	2q6g	REPLICASE POLYPROTEIN 1AB (SARS-COV BJ01)	5 / 9	ASN B 84 ASP B 176 PRO B 39 ALA B 41 THR B 175	1.63A	20.00	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_A_NOVA403_1 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	2q6g	REPLICASE POLYPROTEIN 1AB (SARS-COV BJ01)	5 / 10	HIS A 164 ALA A 173 GLU A 47 VAL A 186 ARG A 188	1.67A	22.53	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_B_NOVB403_1 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	2qc2	3C-LIKE PROTEINASE (-)	4 / 7	PHE B 3 ARG B 4 LEU B 282 ALA B 210	1.20A	22.46	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_A_NOVA403_2 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	2qc2	3C-LIKE PROTEINASE (-)	4 / 6	PHE B 3 ARG B 4 LEU B 282 ALA B 210	1.17A	22.46	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_A_NOVA400_1 (DNA GYRASE SUBUNIT B)	2qcy	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	ASP A 295 GLU A 290 ASP A 289 ILE A 136 LYS A 5	1.70A	22.14	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_A_NOVA403_2 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	2qiq	REPLICASE POLYPROTEIN 1AB (SARSr-CoV)	4 / 6	PHE A 3 ARG A 4 LEU A 282 ALA A 210	1.54A	21.45	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_D_NOVD2000_1 (DNA GYRASE SUBUNIT B)	2rhb	URIDYLATE-SPECIFIC ENDORIBONUCLEASE (SARSr-CoV)	5 / 12	GLU C 113 ILE C 99 PRO C 111 ILE C 79 SER C 97	1.68A	21.37	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_A_NOVA403_1 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	2rhb	URIDYLATE-SPECIFIC ENDORIBONUCLEASE (SARSr-CoV)	5 / 10	ALA B 81 PRO B 67 GLU B 68 VAL B 127 ARG B 126	1.56A	22.10	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_1 (DNA GYRASE SUBUNIT B)	2rhb	URIDYLATE-SPECIFIC ENDORIBONUCLEASE (SARSr-CoV)	5 / 12	ARG E 90 ILE F 42 PRO E 270 ASP E 267 ALA F 22	1.54A	22.36	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_A_NOVA400_1 (DNA GYRASE SUBUNIT B)	2rhb	URIDYLATE-SPECIFIC ENDORIBONUCLEASE (SARSr-CoV)	5 / 12	ASP F 36 ARG E 90 ILE E 269 PRO E 270 THR F 33	1.58A	22.36	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_A_NOVA2000_1 (DNA GYRASE SUBUNIT B)	2rhb	URIDYLATE-SPECIFIC ENDORIBONUCLEASE (SARSr-CoV)	5 / 12	GLU D 113 ILE D 99 PRO D 111 ILE D 79 SER D 97	1.69A	21.37	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_C_NOVC2000_1 (DNA GYRASE SUBUNIT B)	2rhb	URIDYLATE-SPECIFIC ENDORIBONUCLEASE (SARSr-CoV)	5 / 12	ILE D 99 PRO D 111 ALA D 81 ILE D 79 SER D 97	1.60A	21.37	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_A_NOVA403_2 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	2rhb	URIDYLATE-SPECIFIC ENDORIBONUCLEASE (SARSr-CoV)	4 / 6	PHE B 213 LEU B 214 ALA B 255 GLN B 208	1.55A	22.10	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_A_NOVA400_2 (DNA GYRASE SUBUNIT B)	2rhb	URIDYLATE-SPECIFIC ENDORIBONUCLEASE (SARSr-CoV)	3 / 3	ASN D 52 PHE B 55 VAL B 24	0.77A	22.36	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_2 (DNA GYRASE SUBUNIT B)	2w2g	NSP3 (SARSr-CoV)	3 / 3	ASP A 481 PHE A 511 VAL A 478	1.30A	20.15	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_2 (DNA GYRASE SUBUNIT B)	2xyq	PUTATIVE 2'-O-METHYL TRANSFERASE (SARSr-CoV)	3 / 3	ASP A 114 PHE A 70 VAL A 118	1.14A	21.50	SAH A1293 (-3.7A) None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_2 (DNA GYRASE SUBUNIT B)	2xyv	PUTATIVE 2'-O-METHYL TRANSFERASE (SARSr-CoV)	3 / 3	ASP A 114 PHE A 70 VAL A 118	1.11A	21.30	SAH A1300 (-3.8A) None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1AJ6_A_NOVA1_1 (GYRASE)	2z9k	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 9	ASN B 238 GLU B 240 ILE B 200 ALA B 129 THR B 201	1.78A	20.00	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URN_A_NOVA2000_1 (DNA TOPOISOMERASE IV, B SUBUNIT)	2z9k	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 11	ASP A 295 GLU A 290 ASP A 289 ARG B 4 ILE A 106	1.61A	19.29	DMS A 813 ( 4.5A) None None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_A_NOVA403_2 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	3aw0	3C-LIKE PROTEINASE (SARSr-CoV)	4 / 6	PHE A 3 ARG A 4 LEU A 282 ALA A 210	1.50A	22.84	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1S14_A_NOVA1300_1 (TOPOISOMERASE IV SUBUNIT B)	3bgf	F26G19 FAB SPIKE PROTEIN S1 (Mus musculus; SARSr-CoV)	5 / 12	ASN A 424 ASP B 56 ASP B 101 ILE A 489 THR B 31	1.69A	23.81	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_2 (DNA GYRASE SUBUNIT B)	3bgf	SPIKE PROTEIN S1 (SARSr-CoV)	3 / 3	ASP S 385 PHE S 416 VAL S 420	1.32A	19.54	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_A_NOVA403_1 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	3bgf	F26G19 FAB (Mus musculus)	5 / 10	LEU B 69 ALA B 67 GLU B 5 SER B 7 VAL B 18	1.53A	20.31	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_B_NOVB403_1 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	3d0g	SPIKE GLYCOPROTEIN (SARSr-CoV)	4 / 7	ARG E 449 LEU E 448 ALA E 406 GLN E 396	1.32A	19.61	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_A_NOVA400_2 (DNA GYRASE SUBUNIT B)	3d0g	SPIKE GLYCOPROTEIN (SARSr-CoV)	3 / 3	ASN E 375 PHE E 325 VAL E 382	0.93A	21.90	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1S14_B_NOVB2300_1 (TOPOISOMERASE IV SUBUNIT B)	3d0g	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER F 386 ASP F 385 ASP F 351 ALA F 350 ILE F 345	1.55A	21.86	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1S14_A_NOVA1300_1 (TOPOISOMERASE IV SUBUNIT B)	3d0g	ACE2 (Paguma larvata; Homo sapiens; SARSr-CoV)	5 / 12	ASN A 437 GLU A 435 ASP A 431 PRO A 415 ILE A 291	1.54A	14.52	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_D_NOVD2000_1 (DNA GYRASE SUBUNIT B)	3d0g	ACE2 (Paguma larvata; Homo sapiens; SARSr-CoV)	5 / 12	ASN A 437 GLU A 435 ASP A 431 ILE A 291 PRO A 415	1.75A	17.96	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_A_NOVA400_2 (DNA GYRASE SUBUNIT B)	3d0h	SPIKE GLYCOPROTEIN (SARSr-CoV)	3 / 3	ASN F 375 PHE F 325 VAL F 382	0.96A	21.94	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_B_NOVB403_1 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	3d0h	ACE2 (Paguma larvata; Homo sapiens; SARSr-CoV)	4 / 7	PHE A 32 LEU A 29 ALA A 80 GLN A 81	1.42A	16.92	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_2 (DNA GYRASE SUBUNIT B)	3d0h	ACE2 (Paguma larvata; Homo sapiens; SARSr-CoV)	3 / 3	ASP B 367 PHE B 369 VAL B 293	1.29A	21.32	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1S14_B_NOVB2300_1 (TOPOISOMERASE IV SUBUNIT B)	3d0h	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER F 386 ASP F 385 ASP F 351 ALA F 350 ILE F 345	1.43A	22.33	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_B_NOVB403_1 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	3d0h	SPIKE GLYCOPROTEIN (SARSr-CoV)	4 / 7	ARG F 449 LEU F 448 ALA F 406 GLN F 396	1.44A	18.25	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_A_NOVA400_2 (DNA GYRASE SUBUNIT B)	3d0i	SPIKE GLYCOPROTEIN (SARSr-CoV)	3 / 3	ASN F 375 PHE F 325 VAL F 382	0.90A	21.59	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_C_NOVC2000_1 (DNA GYRASE SUBUNIT B)	3d0i	ACE2 (Paguma larvata; Homo sapiens; SARSr-CoV)	5 / 12	ASN A 437 GLU A 435 ASP A 431 ILE A 291 ALA A 413	1.65A	17.96	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1S14_B_NOVB2300_1 (TOPOISOMERASE IV SUBUNIT B)	3d0i	ACE2 (Paguma larvata; Homo sapiens; SARSr-CoV)	5 / 12	ASN A 437 GLU A 435 ASP A 431 PRO A 415 ALA A 413	1.75A	14.52	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1AJ6_A_NOVA1_1 (GYRASE)	3d0i	ACE2 (Paguma larvata; Homo sapiens; SARSr-CoV)	5 / 9	ASN A 437 GLU A 435 ASP A 431 ILE A 291 ALA A 413	1.68A	16.14	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_1 (DNA GYRASE SUBUNIT B)	3d0i	ACE2 (Paguma larvata; Homo sapiens; SARSr-CoV)	5 / 12	ASN A 437 GLU A 435 ASP A 431 ILE A 291 PRO A 415	1.56A	21.32	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1S14_B_NOVB2300_1 (TOPOISOMERASE IV SUBUNIT B)	3d0i	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER F 386 ASP F 385 ASP F 351 ALA F 350 ILE F 345	1.42A	21.86	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_B_NOVB403_1 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	3d0i	SPIKE GLYCOPROTEIN (SARSr-CoV)	4 / 7	ARG F 449 LEU F 448 ALA F 406 GLN F 396	1.41A	18.25	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_A_NOVA403_2 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	3ea7	3C-LIKE PROTEINASE (SARSr-CoV)	4 / 6	PHE A 3 ARG A 4 LEU A 282 ALA A 210	1.48A	21.12	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_A_NOVA2000_1 (DNA GYRASE SUBUNIT B)	3eaj	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	ASN B 133 ASP A 245 ASP B 176 ILE B 136 ARG B 105	1.66A	23.13	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_1 (DNA GYRASE SUBUNIT B)	3eaj	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	ASP B 248 PRO A 132 ASP A 289 ILE A 136 ALA A 173	1.80A	23.00	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_A_NOVA403_2 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	3ebn	REPLICASE POLYPROTEIN 1AB (SARSr-CoV)	4 / 6	PHE B 219 ARG D 222 LEU B 208 ALA B 211	1.52A	17.57	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_D_NOVD2000_1 (DNA GYRASE SUBUNIT B)	3f9f	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	GLU B 288 ASP B 289 ILE B 286 ILE A 286 SER A 284	1.57A	23.25	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_A_NOVA403_2 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	3f9f	3C-LIKE PROTEINASE (SARSr-CoV)	4 / 6	PHE B 3 ARG B 4 LEU B 282 ALA B 210	1.49A	22.53	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_A_NOVA2000_1 (DNA GYRASE SUBUNIT B)	3f9f	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	GLU B 288 ASP B 289 ILE B 286 ILE A 286 SER A 284	1.58A	23.25	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_A_NOVA403_2 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	3f9g	3C-LIKE PROTEINASE (SARSr-CoV)	4 / 6	PHE A 3 ARG A 4 LEU A 282 ALA A 210	1.26A	21.14	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_B_NOVB403_1 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	3f9g	3C-LIKE PROTEINASE (SARSr-CoV)	4 / 7	PHE A 3 ARG A 4 LEU A 282 ALA A 210	1.30A	21.14	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_A_NOVA2000_1 (DNA GYRASE SUBUNIT B)	3f9g	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	GLU B 288 ASP B 289 ILE B 286 ILE A 286 SER A 284	1.60A	23.62	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_D_NOVD2000_1 (DNA GYRASE SUBUNIT B)	3f9g	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	GLU B 288 ASP B 289 ILE B 286 ILE A 286 SER A 284	1.57A	23.62	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_A_NOVA403_2 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	3fzd	3C-LIKE PROTEINASE (SARSr-CoV)	4 / 6	PHE A 3 ARG A 4 LEU A 282 ALA A 210	1.53A	20.90	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_A_NOVA403_1 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	3i6g	HLA, A-2 MEMBRANE PROTEIN (Homo sapiens)	5 / 10	HIS A 74 ALA A 69 TYR C 6 GLU A 148 VAL A 76	1.67A	21.50	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_B_NOVB403_1 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	3i6k	HLA, A-2 (Homo sapiens)	4 / 7	PHE A 36 ARG A 35 GLN A 72 GLN A 32	1.19A	21.50	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1S14_B_NOVB2300_1 (TOPOISOMERASE IV SUBUNIT B)	3i6k	HLA, A-2 (Homo sapiens)	5 / 12	ASP E 106 PRO A 210 ASP A 30 ALA A 211 ILE A 213	1.77A	20.51	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_B_NOVB403_1 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	3i6l	HLA, A-24 (Homo sapiens)	4 / 7	PHE D 36 ARG D 35 GLN D 72 GLN D 32	1.15A	23.73	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_2 (DNA GYRASE SUBUNIT B)	3i6l	BETA-2-MICROGLOBULIN HLA, A-24 (Homo sapiens)	3 / 3	ASP D 119 PHE E 62 VAL D 12	1.16A	22.96	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_A_NOVA403_1 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	3iwm	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 10	HIS A 164 ALA A 173 GLU A 47 VAL A 186 ARG A 188	1.70A	22.53	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_A_NOVA403_2 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	3m3s	3C-LIKE PROTEINASE (SARSr-CoV)	4 / 6	PHE A 3 ARG A 4 LEU A 282 ALA A 210	1.50A	22.46	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URN_A_NOVA2000_1 (DNA TOPOISOMERASE IV, B SUBUNIT)	3m3v	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 11	ASP B 295 GLU B 290 ASP B 289 ARG A 4 ILE B 106	1.75A	19.55	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_2 (DNA GYRASE SUBUNIT B)	3r24	2'-O-METHYL TRANSFERASE (SARSr-CoV)	3 / 3	ASP A 114 PHE A 70 VAL A 118	1.03A	22.78	SAM A 302 (-3.4A) None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_B_NOVB403_1 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	3sci	SPIKE GLYCOPROTEIN (SARSr-CoV)	4 / 7	ARG F 449 LEU F 448 ALA F 406 GLN F 396	1.37A	22.09	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_B_NOVB403_1 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	3scj	SPIKE GLYCOPROTEIN (SARSr-CoV)	4 / 7	ARG F 449 LEU F 448 ALA F 406 GLN F 396	1.44A	20.16	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1S14_B_NOVB2300_1 (TOPOISOMERASE IV SUBUNIT B)	3scj	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER F 386 ASP F 385 ASP F 351 ALA F 350 ILE F 345	1.43A	21.86	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_A_NOVA400_2 (DNA GYRASE SUBUNIT B)	3scj	SPIKE GLYCOPROTEIN (SARSr-CoV)	3 / 3	ASN F 375 PHE F 325 VAL F 382	1.16A	17.01	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1S14_B_NOVB2300_1 (TOPOISOMERASE IV SUBUNIT B)	3sck	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER E 386 ASP E 385 ASP E 351 ALA E 350 ILE E 345	1.41A	21.86	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_2 (DNA GYRASE SUBUNIT B)	3sck	ACE2 (Paguma larvata; Homo sapiens; SARSr-CoV)	3 / 3	ASP B 367 PHE B 369 VAL B 293	1.36A	21.05	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1S14_B_NOVB2300_1 (TOPOISOMERASE IV SUBUNIT B)	3scl	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER E 386 ASP E 385 ASP E 351 ALA E 350 ILE E 345	1.47A	21.86	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_A_NOVA400_2 (DNA GYRASE SUBUNIT B)	3scl	SPIKE GLYCOPROTEIN (SARSr-CoV)	3 / 3	ASN E 375 PHE E 325 VAL E 382	1.02A	18.45	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_2 (DNA GYRASE SUBUNIT B)	3to2	BETA-2-MICROGLOBULIN MHC CLASS I ANTIGEN (Homo sapiens)	3 / 3	ASP A 119 PHE B 62 VAL A 12	1.13A	21.32	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_A_NOVA403_2 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	3to2	MD3-C9 PEPTIDE DERIVED FROM MEMBRANE GLYCOPROTEIN MHC CLASS I ANTIGEN (Homo sapiens; SARS-COV TJF)	4 / 6	PHE C 4 LEU C 6 ALA A 69 GLN A 155	1.49A	5.00	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_1 (DNA GYRASE SUBUNIT B)	4hi3	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	ASN A 203 GLU A 290 ARG B 4 ALA A 206 THR A 111	1.75A	21.78	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_C_NOVC2000_1 (DNA GYRASE SUBUNIT B)	4m0w	UBIQUITIN (Bos taurus)	5 / 12	ILE B 30 PRO B 38 ASP B 39 GLN B 40 ILE B 36	1.69A	18.18	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_1 (DNA GYRASE SUBUNIT B)	4m0w	REPLICASE POLYPROTEIN 1A UBIQUITIN (Bos taurus; SARSr-CoV)	5 / 12	ARG B 74 ASP B 52 ALA A 154 ARG B 42 THR A 169	1.54A	11.79	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_A_NOVA2000_1 (DNA GYRASE SUBUNIT B)	4m0w	UBIQUITIN (Bos taurus)	5 / 12	ILE B 30 PRO B 38 ASP B 39 GLN B 40 ILE B 36	1.61A	18.18	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_D_NOVD2000_1 (DNA GYRASE SUBUNIT B)	4mm3	PAPAIN-LIKE PROTEINASE UBIQUITIN (Homo sapiens; SARSr-CoV)	5 / 12	GLU A 51 ASP A 52 ASP B 303 SER B 156 ARG B 167	1.80A	18.18	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1S14_A_NOVA1300_1 (TOPOISOMERASE IV SUBUNIT B)	4mm3	PAPAIN-LIKE PROTEINASE UBIQUITIN (Homo sapiens; SARSr-CoV)	5 / 12	SER B 156 GLU B 168 ARG A 42 ARG B 167 THR B 169	1.80A	20.68	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LPS_A_NOVA901_1 (TOPOISOMERASE IV SUBUNIT B)	4mm3	PAPAIN-LIKE PROTEINASE UBIQUITIN (Homo sapiens; SARSr-CoV)	5 / 12	SER B 156 GLU B 168 ARG A 42 ARG B 167 THR B 169	1.74A	22.35	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_A_NOVA400_2 (DNA GYRASE SUBUNIT B)	4ow0	PAPAIN-LIKE PROTEASE (SARS-COV Urbani)	3 / 3	ASN B 178 PHE B 242 VAL B 126	1.36A	23.10	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URN_A_NOVA2000_1 (DNA TOPOISOMERASE IV, B SUBUNIT)	4ow0	PAPAIN-LIKE PROTEASE (SARS-COV Urbani)	5 / 11	SER A 79 GLU A 78 ASP A 77 ARG A 66 THR A 75	1.76A	21.02	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_A_NOVA403_1 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	4rna	PAPAIN-LIKE PROTEASE (Human betacoronavirus 2c EMC/2012)	5 / 10	HIS A 281 ALA A 282 TYR A 279 SER A 167 VAL A 310	1.80A	20.12	None None None None PO4 A 404 ( 4.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_1 (DNA GYRASE SUBUNIT B)	4tww	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	ASN B 203 GLU B 290 ARG A 4 ALA B 206 THR B 111	1.73A	21.88	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_A_NOVA403_2 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	5b6o	3C-LIKE PROTEINASE (SARSr-CoV)	4 / 6	PHE B 3 ARG B 4 LEU B 282 ALA B 210	1.48A	21.86	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_A_NOVA403_1 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	5c8s	GUANINE-N7 METHYLTRANSFERASE (SARSr-CoV)	5 / 10	ALA B 353 TYR B 351 GLU B 347 SER D 307 ARG D 310	1.72A	20.98	SAH B 605 (-3.5A) None None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1AJ6_A_NOVA1_1 (GYRASE)	5c8s	GUANINE-N7 METHYLTRANSFERASE (SARSr-CoV)	5 / 9	ASN D 71 GLU D 204 ARG D 213 ALA D 79 ILE D 74	1.59A	16.51	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1S14_B_NOVB2300_1 (TOPOISOMERASE IV SUBUNIT B)	5c8t	GUANINE-N7 METHYLTRANSFERASE (SARSr-CoV)	5 / 12	ASN D 71 GLU D 204 ARG D 213 ALA D 79 ILE D 74	1.66A	16.47	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1AJ6_A_NOVA1_1 (GYRASE)	5c8t	GUANINE-N7 METHYLTRANSFERASE (SARSr-CoV)	5 / 9	ASN D 71 GLU D 204 ARG D 213 ALA D 79 ILE D 74	1.54A	16.48	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_D_NOVD2000_1 (DNA GYRASE SUBUNIT B)	5c8t	GUANINE-N7 METHYLTRANSFERASE (SARSr-CoV)	5 / 12	ASN B 408 SER B 407 ILE B 298 PRO B 297 ILE B 299	1.72A	17.01	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1AJ6_A_NOVA1_1 (GYRASE)	5e6j	POLYUBIQUITIN-B (synthetic construct)	5 / 9	GLU F 51 ASP F 52 ARG F 54 ALA F 46 ILE F 44	1.74A	15.98	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_1 (DNA GYRASE SUBUNIT B)	5e6j	REPLICASE POLYPROTEIN 1AB UBIQUITIN (SARSr-CoV; synthetic construct)	5 / 12	ARG E 72 ASP E 52 ALA D 154 ARG E 42 THR D 169	1.61A	11.79	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1S14_B_NOVB2300_1 (TOPOISOMERASE IV SUBUNIT B)	5e6j	POLYUBIQUITIN-B REPLICASE POLYPROTEIN 1AB (SARSr-CoV; synthetic construct)	5 / 12	GLU F 51 ASP F 52 ASP D 63 ALA F 46 ILE F 44	1.66A	19.27	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URN_A_NOVA2000_1 (DNA TOPOISOMERASE IV, B SUBUNIT)	5e6j	REPLICASE POLYPROTEIN 1AB (SARSr-CoV)	5 / 11	SER D 79 GLU D 78 ASP D 77 ARG D 66 THR D 75	1.59A	20.85	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1AJ6_A_NOVA1_1 (GYRASE)	5f22	NSP8 (SARSr-CoV)	5 / 9	ASN B 105 ASP B 104 ILE B 112 ALA B 115 ILE B 111	1.64A	22.17	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_1 (DNA GYRASE SUBUNIT B)	5f22	NSP8 (SARSr-CoV)	5 / 12	ASN B 105 ARG B 101 ILE B 112 ALA B 107 ARG B 116	1.77A	15.83	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_C_NOVC2000_1 (DNA GYRASE SUBUNIT B)	5f22	NSP8 (SARSr-CoV)	5 / 12	ASN B 105 ASP B 104 ILE B 112 ALA B 115 ILE B 111	1.69A	19.83	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_D_NOVD2000_1 (DNA GYRASE SUBUNIT B)	5f22	NSP8 (SARSr-CoV)	5 / 12	ASN B 105 ASP B 104 ILE B 112 ASP B 117 ILE B 111	1.65A	19.83	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_A_NOVA2000_1 (DNA GYRASE SUBUNIT B)	5f22	NSP8 (SARSr-CoV)	5 / 12	ASN B 105 ASP B 104 ILE B 112 ASP B 117 ILE B 111	1.69A	19.83	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_A_NOVA403_1 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	5nfy	POLYPROTEIN 1AB (SARS-COV Frankfurt 1)	5 / 10	LEU C 209 HIS C 229 ALA A 225 SER C 221 VAL C 231	1.79A	20.98	PEG C 604 (-4.5A) ZN C 601 (-2.9A) None PEG A 604 (-3.2A) None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1S14_B_NOVB2300_1 (TOPOISOMERASE IV SUBUNIT B)	5nfy	POLYPROTEIN 1AB (SARS-COV Frankfurt 1)	5 / 12	ASN D 386 ARG D 289 PRO D 429 ASP D 415 ALA D 430	1.67A	16.28	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1AJ6_A_NOVA1_1 (GYRASE)	5nfy	POLYPROTEIN 1AB (SARS-COV Frankfurt 1)	5 / 9	ASN A 71 GLU A 204 ARG A 213 ALA A 79 ILE A 74	1.47A	16.10	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_A_NOVA400_2 (DNA GYRASE SUBUNIT B)	5tl7	REPLICASE POLYPROTEIN 1AB (SARSr-CoV)	3 / 3	ASN D 178 PHE D 242 VAL D 126	1.36A	23.30	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_B_NOVB403_1 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	5tl7	UBIQUITIN-LIKE PROTEIN ISG15 (Mus musculus)	4 / 7	PHE A 120 ARG A 151 ARG A 153 GLN A 111	1.40A	19.68	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_2 (DNA GYRASE SUBUNIT B)	5tl7	UBIQUITIN-LIKE PROTEIN ISG15 (Mus musculus)	3 / 3	ASP C 103 PHE C 120 VAL C 109	1.23A	13.35	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_A_NOVA2000_1 (DNA GYRASE SUBUNIT B)	5wrg	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	ARG C 977 ILE A 979 GLN A 974 ILE A 975 SER A 728	1.78A	10.64	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_2 (DNA GYRASE SUBUNIT B)	5wrg	SPIKE GLYCOPROTEIN (SARSr-CoV)	3 / 3	ASP B 572 PHE B 527 VAL B 562	1.39A	15.94	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_B_NOVB403_1 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	5wrg	SPIKE GLYCOPROTEIN (SARSr-CoV)	4 / 7	PHE C 764 ARG C 761 ALA C1037 GLN C1036	1.42A	11.55	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_2 (DNA GYRASE SUBUNIT B)	5x4r	S PROTEIN (MERS-CoV)	3 / 3	ASP A 83 PHE A 147 VAL A 118	1.07A	20.65	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_D_NOVD2000_1 (DNA GYRASE SUBUNIT B)	5x4s	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER A 120 ILE A 152 PRO A 136 ILE A 115 THR A 150	1.44A	19.16	NAG A 602 (-3.3A) None None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_A_NOVA403_2 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	5x58	SPIKE GLYCOPROTEIN (SARS-COV BJ01)	4 / 6	PHE B 629 LEU B 636 ALA B 676 GLN B 599	1.52A	11.40	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1S14_A_NOVA1300_1 (TOPOISOMERASE IV SUBUNIT B)	5x58	SPIKE GLYCOPROTEIN (SARS-COV BJ01)	5 / 12	ASN C 530 ASP C 376 ARG A 965 ASP C 557 THR C 533	1.61A	9.39	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_2 (DNA GYRASE SUBUNIT B)	5x58	SPIKE GLYCOPROTEIN (SARS-COV BJ01)	3 / 3	ASP C 166 PHE C 220 VAL C 123	1.18A	15.46	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_B_NOVB403_1 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	5x58	SPIKE GLYCOPROTEIN (SARS-COV BJ01)	4 / 7	ARG B 982 LEU B 983 GLN A 947 GLN B 947	1.42A	11.40	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_A_NOVA2000_1 (DNA GYRASE SUBUNIT B)	5x58	SPIKE GLYCOPROTEIN (SARS-COV BJ01)	5 / 12	SER A 113 ARG A 126 ILE A 152 GLN A 147 ILE A 234	1.76A	10.26	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1S14_B_NOVB2300_1 (TOPOISOMERASE IV SUBUNIT B)	5x58	SPIKE GLYCOPROTEIN (SARS-COV BJ01)	5 / 12	SER B 386 ASP B 385 ASP B 351 ALA B 350 ILE B 345	1.46A	9.39	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1AJ6_A_NOVA1_1 (GYRASE)	5x58	SPIKE GLYCOPROTEIN (SARS-COV BJ01)	5 / 9	ASN C1080 ILE C 696 PRO C 697 ALA C 695 THR C1087	1.71A	10.83	None None None NAG C1305 ( 4.8A) None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_C_NOVC2000_1 (DNA GYRASE SUBUNIT B)	5x59	S PROTEIN (MERS-CoV)	5 / 12	ASN B 719 ASP C 910 ALA B 678 ILE B 682 SER B 684	1.65A	10.51	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1S14_B_NOVB2300_1 (TOPOISOMERASE IV SUBUNIT B)	5x59	S PROTEIN (MERS-CoV)	5 / 12	ASN C 226 ASP C 174 PRO C 210 ASP C 306 ALA C 211	1.64A	8.96	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_D_NOVD2000_1 (DNA GYRASE SUBUNIT B)	5x59	S PROTEIN (MERS-CoV)	5 / 12	ASN B 719 SER B 720 ASP C 910 ILE B 682 SER B 684	1.61A	10.51	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_2 (DNA GYRASE SUBUNIT B)	5x59	S PROTEIN (MERS-CoV)	3 / 3	ASP A 83 PHE A 147 VAL A 118	1.07A	15.65	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_A_NOVA2000_1 (DNA GYRASE SUBUNIT B)	5x59	S PROTEIN (MERS-CoV)	5 / 12	ASN B 719 SER B 720 ASP C 910 ILE B 682 SER B 684	1.65A	10.51	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_1 (DNA GYRASE SUBUNIT B)	5x5b	SPIKE GLYCOPROTEIN (SARS-COV BJ01)	5 / 12	ASP C 296 ILE C 650 PRO C 651 ILE C 584 ALA C 595	1.32A	15.46	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_C_NOVC2000_1 (DNA GYRASE SUBUNIT B)	5x5b	SPIKE GLYCOPROTEIN (SARS-COV BJ01)	5 / 12	ILE B 696 GLN C 877 ALA B 695 ILE B 694 ARG B1055	1.44A	10.26	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_A_NOVA400_2 (DNA GYRASE SUBUNIT B)	5x5b	SPIKE GLYCOPROTEIN (SARS-COV BJ01)	3 / 3	ASN A 119 PHE A 153 VAL A 124	1.43A	15.46	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_D_NOVD2000_1 (DNA GYRASE SUBUNIT B)	5x5b	SPIKE GLYCOPROTEIN (SARS-COV BJ01)	5 / 12	SER A1093 ARG A1089 ILE A1086 PRO A1072 ILE A1097	1.80A	10.26	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_A_NOVA403_2 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	5x5c	S PROTEIN (MERS-CoV)	4 / 6	ARG C1057 LEU C1058 ALA C1065 GLN C1056	1.45A	11.96	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_B_NOVB403_1 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	5x5f	S PROTEIN (MERS-CoV)	4 / 7	PHE A 473 ALA A 520 GLN A 522 GLN A 427	1.20A	11.96	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_A_NOVA400_2 (DNA GYRASE SUBUNIT B)	5x5f	S PROTEIN (MERS-CoV)	3 / 3	ASN A 839 PHE A1081 VAL A 802	1.03A	15.65	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_A_NOVA400_2 (DNA GYRASE SUBUNIT B)	5xlr	SPIKE GLYCOPROTEIN (SARSr-CoV)	3 / 3	ASN B 214 PHE B 262 VAL B 40	1.26A	15.94	ASN B 214 ( 0.6A) PHE B 262 ( 1.3A) VAL B 40 ( 0.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_A_NOVA400_2 (DNA GYRASE SUBUNIT B)	5y3e	REPLICASE POLYPROTEIN 1A (SARSr-CoV)	3 / 3	ASN A 178 PHE A 242 VAL A 126	1.46A	20.97	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_B_NOVB403_1 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	6acd	SPIKE GLYCOPROTEIN (SARSr-CoV)	4 / 7	PHE B 764 ARG B 761 ALA B1037 GLN B1036	1.37A	11.64	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1S14_B_NOVB2300_1 (TOPOISOMERASE IV SUBUNIT B)	6acd	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	GLU B 452 ASP B 454 ARG B 449 PRO B 450 ASP B 414	1.59A	9.95	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_A_NOVA400_1 (DNA GYRASE SUBUNIT B)	6acd	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	GLU B 452 ASP B 454 ARG B 449 PRO B 450 ASP B 414	1.59A	15.42	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LPS_A_NOVA901_1 (TOPOISOMERASE IV SUBUNIT B)	6acd	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	GLU B 452 ASP B 454 ARG B 449 PRO B 450 ASP B 414	1.68A	16.32	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_A_NOVA400_2 (DNA GYRASE SUBUNIT B)	6acg	SPIKE GLYCOPROTEIN (SARSr-CoV)	3 / 3	ASN A 119 PHE A 153 VAL A 124	0.79A	15.42	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_A_NOVA403_1 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	6acg	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 10	LEU A 810 ALA A 938 PRO A1039 GLU A 801 VAL A 842	1.61A	11.64	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LPS_A_NOVA901_1 (TOPOISOMERASE IV SUBUNIT B)	6acg	ACE2 (Homo sapiens)	5 / 12	ASP D 471 GLU D 495 ASP D 494 PRO D 178 THR D 496	1.75A	21.70	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_2 (DNA GYRASE SUBUNIT B)	6acg	SPIKE GLYCOPROTEIN (SARSr-CoV)	3 / 3	ASP A 385 PHE A 325 VAL A 382	1.06A	15.42	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_1 (DNA GYRASE SUBUNIT B)	6acg	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	ILE A 652 PRO A 651 ILE A 584 ALA A 595 THR A 631	1.57A	15.42	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_D_NOVD2000_1 (DNA GYRASE SUBUNIT B)	6acg	ACE2 (Homo sapiens)	5 / 12	GLU D 312 ILE D 379 ILE D 358 SER D 331 THR D 324	1.79A	17.62	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_C_NOVC2000_1 (DNA GYRASE SUBUNIT B)	6acj	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	ASN A 189 ARG B 342 ILE A 226 ALA A 127 ARG B 453	1.52A	10.72	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_B_NOVB403_1 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	6acj	ACE2 (Homo sapiens)	4 / 7	PHE D 32 LEU D 29 ALA D 80 GLN D 101	1.35A	17.91	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1S14_B_NOVB2300_1 (TOPOISOMERASE IV SUBUNIT B)	6ack	ACE2 (Homo sapiens)	5 / 12	ASP D 471 GLU D 495 ASP D 494 PRO D 500 ALA D 501	1.74A	14.86	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_A_NOVA2000_1 (DNA GYRASE SUBUNIT B)	6ack	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER A 949 ASP B 557 ASP A 727 ILE A 724 SER A 985	1.58A	10.72	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_D_NOVD2000_1 (DNA GYRASE SUBUNIT B)	6ack	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	GLU B 452 ASP B 454 ARG B 449 PRO B 450 ASP B 414	1.67A	10.72	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1AJ6_A_NOVA1_1 (GYRASE)	6ack	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 9	ARG B1073 ILE B1063 PRO B1072 ALA B1062 ILE B1115	1.53A	11.07	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_A_NOVA400_1 (DNA GYRASE SUBUNIT B)	6ack	ACE2 (Homo sapiens)	5 / 12	ASP D 206 GLU D 398 ARG D 514 ILE D 513 THR D 517	1.64A	21.05	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_2 (DNA GYRASE SUBUNIT B)	6ack	ACE2 (Homo sapiens)	3 / 3	ASP D 509 PHE D 464 VAL D 506	1.28A	21.05	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1S14_A_NOVA1300_1 (TOPOISOMERASE IV SUBUNIT B)	6ack	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	GLU B 452 ASP B 454 ARG B 449 PRO B 450 ASP B 414	1.70A	9.95	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_1 (DNA GYRASE SUBUNIT B)	6crv	SPIKE GLYCOPROTEIN,FIBRITI N (SARSr-CoV)	5 / 12	ASN C1056 GLU C1054 ILE C 696 ILE C 694 THR C 698	1.68A	15.59	NAG C1310 (-1.8A) None None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1AJ6_A_NOVA1_1 (GYRASE)	6crv	SPIKE GLYCOPROTEIN,FIBRITI N (SARSr-CoV)	5 / 9	ASN C1056 GLU C1054 ILE C 696 ILE C 694 THR C 698	1.75A	10.76	NAG C1310 (-1.8A) None None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_A_NOVA403_2 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	6crw	SPIKE GLYCOPROTEIN,FIBRITI N (SARSr-CoV)	4 / 6	PHE A 137 ARG A 232 LEU A 235 ALA A 237	1.53A	11.36	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_A_NOVA400_2 (DNA GYRASE SUBUNIT B)	6crw	SPIKE GLYCOPROTEIN,FIBRITI N (SARSr-CoV)	3 / 3	ASN B1107 PHE B1071 VAL B1110	0.54A	15.59	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_C_NOVC2000_1 (DNA GYRASE SUBUNIT B)	6crw	SPIKE GLYCOPROTEIN,FIBRITI N (SARSr-CoV)	5 / 12	ASP B 849 PRO B 844 ASP A 600 GLN A 599 ALA A 633	1.50A	10.93	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1S14_B_NOVB2300_1 (TOPOISOMERASE IV SUBUNIT B)	6crx	SPIKE GLYCOPROTEIN,FIBRITI N (SARSr-CoV)	5 / 12	SER C 386 ASP C 385 ASP C 351 ALA C 350 ILE C 345	1.46A	9.70	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_2 (DNA GYRASE SUBUNIT B)	6crz	SPIKE GLYCOPROTEIN,FIBRITI N (SARSr-CoV)	3 / 3	ASP B 385 PHE B 329 VAL B 382	1.07A	15.59	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1AJ6_A_NOVA1_1 (GYRASE)	6cs1	SPIKE GLYCOPROTEIN,FIBRITI N (SARSr-CoV)	5 / 9	ASN A 119 ILE A 152 PRO A 136 ILE A 115 THR A 150	1.52A	10.78	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_D_NOVD2000_1 (DNA GYRASE SUBUNIT B)	6cs1	SPIKE GLYCOPROTEIN,FIBRITI N (SARSr-CoV)	5 / 12	ASN A 119 ILE A 152 PRO A 136 ILE A 115 THR A 150	1.51A	10.93	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_A_NOVA2000_1 (DNA GYRASE SUBUNIT B)	6cs1	SPIKE GLYCOPROTEIN,FIBRITI N (SARSr-CoV)	5 / 12	ASN A1117 ILE A1097 ASP A1100 ILE A1096 SER A1083	1.47A	10.93	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_1 (DNA GYRASE SUBUNIT B)	6cs2	SPIKE GLYCOPROTEIN,FIBRITI N (SARSr-CoV)	5 / 12	GLU A 999 ILE A 995 ILE B 995 ALA C 998 ARG A 996	1.51A	15.59	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_B_NOVB403_1 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	6cs2	SPIKE GLYCOPROTEIN,FIBRITI N (SARSr-CoV)	4 / 7	ARG B 982 LEU B 986 GLN B 744 GLN B 947	1.36A	11.36	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_B_NOVB403_1 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	6iex	MHC CLASS I ANTIGEN (Homo sapiens)	4 / 7	ARG A 75 LEU A 78 GLN A 87 GLN A 72	1.44A	23.88	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1AJ6_A_NOVA1_1 (GYRASE)	6jyt	HELICASE (SARSr-CoV)	5 / 9	ARG A 443 ILE A 448 PRO A 445 ALA A 469 ILE A 572	1.46A	17.42	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_A_NOVA403_2 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	6jyt	HELICASE (SARSr-CoV)	4 / 6	PHE B 200 ARG B 178 LEU B 176 ALA B 152	1.39A	18.59	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_A_NOVA2000_1 (DNA GYRASE SUBUNIT B)	6jyt	HELICASE (SARSr-CoV)	5 / 12	ASN A 349 SER A 350 ILE A 333 ASP A 315 ILE A 334	1.60A	16.14	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_D_NOVD2000_1 (DNA GYRASE SUBUNIT B)	6jyt	HELICASE (SARSr-CoV)	5 / 12	ASN A 349 SER A 350 ILE A 333 ASP A 315 ILE A 334	1.69A	16.14	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_C_NOVC2000_1 (DNA GYRASE SUBUNIT B)	6jyt	HELICASE (SARSr-CoV)	5 / 12	ILE A 448 PRO A 445 GLN A 470 ALA A 469 ILE A 572	1.59A	16.14	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_2 (DNA GYRASE SUBUNIT B)	6jyt	HELICASE (SARSr-CoV)	3 / 3	ASP A 435 PHE A 291 VAL A 272	1.08A	20.55	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1S14_B_NOVB2300_1 (TOPOISOMERASE IV SUBUNIT B)	6jyt	HELICASE (SARSr-CoV)	5 / 12	SER A 453 ASP A 458 ASP A 450 ALA A 568 ILE A 565	1.73A	16.33	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_B_NOVB403_1 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	6m17	ACE2 SODIUM-DEPENDENT NEUTRAL AMINO ACID TRANSPORTER B(0)AT1 (Homo sapiens)	4 / 7	PHE C 348 ARG D 678 ALA C 374 GLN C 377	1.30A	16.54	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_1 (DNA GYRASE SUBUNIT B)	6m17	ACE2 (Homo sapiens)	5 / 12	ASN B 437 GLU B 435 ASP B 431 ILE B 291 PRO B 415	1.69A	20.39	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_A_NOVA400_2 (DNA GYRASE SUBUNIT B)	6m17	SODIUM-DEPENDENT NEUTRAL AMINO ACID TRANSPORTER B(0)AT1 (Homo sapiens)	3 / 3	ASN A 435 PHE A 277 VAL A 125	0.93A	20.86	LEU A 707 (-4.0A) LEU A 707 (-3.3A) None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_D_NOVD2000_1 (DNA GYRASE SUBUNIT B)	6m17	ACE2 (Homo sapiens)	5 / 12	ASN B 437 GLU B 435 ASP B 431 ILE B 291 PRO B 415	1.64A	15.19	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_D_NOVD2000_1 (DNA GYRASE SUBUNIT B)	6m18	SODIUM-DEPENDENT NEUTRAL AMINO ACID TRANSPORTER B(0)AT1 (Homo sapiens)	5 / 12	SER C 151 GLU C 405 ARG C 328 ILE C 407 THR C 408	1.66A	16.31	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_A_NOVA2000_1 (DNA GYRASE SUBUNIT B)	6m18	SODIUM-DEPENDENT NEUTRAL AMINO ACID TRANSPORTER B(0)AT1 (Homo sapiens)	5 / 12	ASN A 293 SER A 294 GLU A 28 ARG A 32 PRO A 33	1.67A	16.31	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_A_NOVA403_1 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	6m18	SODIUM-DEPENDENT NEUTRAL AMINO ACID TRANSPORTER B(0)AT1 (Homo sapiens)	5 / 10	ALA C 247 TYR C 322 PRO C 59 GLU C 394 PHE C 420	1.77A	16.54	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_C_NOVC2000_1 (DNA GYRASE SUBUNIT B)	6m1d	ACE2 (Homo sapiens)	5 / 12	GLU D 208 ASP D 201 ASP D 225 ILE D 513 SER D 511	1.46A	15.19	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_B_NOVB403_1 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	6m1d	ACE2 (Homo sapiens)	4 / 7	PHE D 28 LEU D 29 ALA D 80 GLN D 81	1.42A	15.01	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1S14_A_NOVA1300_1 (TOPOISOMERASE IV SUBUNIT B)	6m1d	ACE2 SODIUM-DEPENDENT NEUTRAL AMINO ACID TRANSPORTER B(0)AT1 (Homo sapiens)	5 / 12	ASN D 636 ASP D 637 PRO D 677 ASP C 349 ILE D 679	1.71A	11.43	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_C_NOVC2000_1 (DNA GYRASE SUBUNIT B)	6m1d	SODIUM-DEPENDENT NEUTRAL AMINO ACID TRANSPORTER B(0)AT1 (Homo sapiens)	5 / 12	GLU C 179 ILE C 183 PRO C 565 ASP C 564 SER C 192	1.79A	16.31	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1S14_B_NOVB2300_1 (TOPOISOMERASE IV SUBUNIT B)	6m1d	ACE2 (Homo sapiens)	5 / 12	ASP D 471 GLU D 495 ASP D 494 PRO D 500 ALA D 501	1.58A	11.43	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_1 (DNA GYRASE SUBUNIT B)	6m1d	SODIUM-DEPENDENT NEUTRAL AMINO ACID TRANSPORTER B(0)AT1 (Homo sapiens)	5 / 12	ASP A 189 ILE A 562 ILE A 576 TYR A 560 THR A 185	1.69A	20.86	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_A_NOVA2000_1 (DNA GYRASE SUBUNIT B)	6m1d	ACE2 (Homo sapiens)	5 / 12	GLU D 208 ASP D 201 ASP D 225 ILE D 513 SER D 511	1.56A	15.19	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_D_NOVD2000_1 (DNA GYRASE SUBUNIT B)	6nb6	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	ASN A1056 GLU A1054 ILE A 696 ILE A 694 THR A 698	1.73A	10.13	NAG A1336 (-1.8A) NAG A1336 (-4.6A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_2 (DNA GYRASE SUBUNIT B)	6nb6	SPIKE GLYCOPROTEIN (SARSr-CoV)	3 / 3	ASP A 376 PHE A 379 VAL A 369	1.27A	15.26	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_A_NOVA400_2 (DNA GYRASE SUBUNIT B)	6nb6	SPIKE GLYCOPROTEIN (SARSr-CoV)	3 / 3	ASN B 942 PHE C 558 VAL B 945	1.30A	15.26	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1AJ6_A_NOVA1_1 (GYRASE)	6nb6	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 9	ASP A1100 ARG A1073 ILE A1086 PRO A1072 THR A1098	1.77A	10.49	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_A_NOVA2000_1 (DNA GYRASE SUBUNIT B)	6nb6	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	SER A1093 ARG A1055 ILE A 696 GLN C 877 ILE A 694	1.72A	10.13	None NAG A1341 (-3.3A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_1 (DNA GYRASE SUBUNIT B)	6nb6	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	ASN A1056 GLU A1054 ILE A 696 ILE A 694 THR A 698	1.60A	15.26	NAG A1336 (-1.8A) NAG A1336 (-4.6A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_B_NOVB403_1 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	6nb7	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 7	ARG B 996 LEU A 994 ALA A 997 GLN A 756 GLN B 993	1.76A	11.73	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_A_NOVA403_1 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	6nb8	S230 ANTIGEN-BINDING (FAB) FRAGMENT, LIGHT CHAIN (Homo sapiens)	5 / 10	LEU L 78 ALA L 19 PRO L 64 VAL L 88 ARG L 44	1.76A	22.18	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_A_NOVA400_2 (DNA GYRASE SUBUNIT B)	6nb8	S230 ANTIGEN-BINDING (FAB) FRAGMENT, HEAVY CHAIN S230 ANTIGEN-BINDING (FAB) FRAGMENT, LIGHT CHAIN (Homo sapiens)	3 / 3	ASN L 142 PHE L 123 VAL H 195	1.13A	18.07	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_A_NOVA400_1 (DNA GYRASE SUBUNIT B)	6nur	NSP8 (SARSr-CoV)	5 / 12	ASP D 99 ILE D 107 ASP D 112 ILE D 106 ARG D 111	1.77A	17.90	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_1 (DNA GYRASE SUBUNIT B)	6nur	NSP8 (SARSr-CoV)	5 / 12	ILE B 106 ASP B 99 ILE B 107 ALA B 110 THR B 123	1.59A	17.90	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_1 (DNA GYRASE SUBUNIT B)	6nur	NSP12 (SARSr-CoV)	5 / 12	ASP A 303 ARG A 640 ILE A 632 ALA A 311 ARG A 651	1.73A	18.53	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_B_NOVB403_1 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	6nur	NSP12 (SARSr-CoV)	4 / 7	PHE A 753 ARG A 750 LEU A 749 ALA A 702	1.28A	14.27	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1AJ6_A_NOVA1_1 (GYRASE)	6nur	NSP8 (SARSr-CoV)	5 / 9	ASN D 100 ASP D 99 ILE D 107 ALA D 110 ILE D 106	1.63A	19.15	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_A_NOVA403_1 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	6nus	NSP12 (SARSr-CoV)	5 / 10	LEU A 576 HIS A 572 ALA A 685 VAL A 662 ARG A 631	1.77A	14.27	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_C_NOVC2000_1 (DNA GYRASE SUBUNIT B)	6nus	NSP12 (SARSr-CoV)	5 / 12	ASN A 691 ASP A 684 ALA A 580 ILE A 589 SER A 759	1.71A	13.72	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_A_NOVA403_2 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	6nus	NSP12 (SARSr-CoV)	4 / 6	PHE A 753 ARG A 750 LEU A 749 ALA A 702	1.21A	14.27	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_A_NOVA2000_1 (DNA GYRASE SUBUNIT B)	6nus	NSP12 NSP8 (SARSr-CoV)	5 / 12	SER A 343 ASP A 377 ILE B 120 PRO B 121 ILE B 106	1.73A	13.72	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1S14_B_NOVB2300_1 (TOPOISOMERASE IV SUBUNIT B)	6nus	NSP12 NSP8 (SARSr-CoV)	5 / 12	ASP B 99 ASP B 112 ALA B 110 ILE B 106 ARG A 331	1.63A	21.60	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_A_NOVA400_2 (DNA GYRASE SUBUNIT B)	6nus	NSP12 (SARSr-CoV)	3 / 3	ASN A 356 PHE A 348 VAL A 535	0.98A	18.53	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_D_NOVD2000_1 (DNA GYRASE SUBUNIT B)	6nus	NSP12 NSP8 (SARSr-CoV)	5 / 12	SER A 343 ASP A 377 ILE B 120 PRO B 121 ILE B 106	1.72A	13.72	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_B_NOVB403_1 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	6vw1	ACE2 (Homo sapiens)	4 / 7	LEU B 418 ALA B 296 GLN B 300 GLN B 442	1.41A	16.92	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_2 (DNA GYRASE SUBUNIT B)	6vw1	SPIKE GLYCOPROTEIN (SARS-CoV-2)	3 / 3	ASP F 398 PHE F 429 VAL F 433	1.36A	23.16	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1S14_B_NOVB2300_1 (TOPOISOMERASE IV SUBUNIT B)	6vw1	SPIKE GLYCOPROTEIN (SARS-CoV-2)	5 / 12	SER E 399 ASP E 398 ASP E 364 ALA E 363 ILE E 358	1.56A	22.36	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_D_NOVD2000_1 (DNA GYRASE SUBUNIT B)	6w41	CR3022 FAB HEAVY CHAIN (Homo sapiens)	5 / 12	GLU H 56 ASP H 54 ARG H 58 ILE H 51 ILE H 34	1.47A	20.60	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_1 (DNA GYRASE SUBUNIT B)	6w41	CR3022 FAB HEAVY CHAIN (Homo sapiens)	5 / 12	GLU H 56 ASP H 54 ARG H 58 ILE H 69 ALA H 78	1.60A	16.15	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1AJ6_A_NOVA1_1 (GYRASE)	6w41	CR3022 FAB HEAVY CHAIN (Homo sapiens)	5 / 9	GLU H 56 ASP H 54 ARG H 58 ILE H 51 ILE H 34	1.47A	20.00	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_A_NOVA2000_1 (DNA GYRASE SUBUNIT B)	6w41	CR3022 FAB HEAVY CHAIN (Homo sapiens)	5 / 12	GLU H 56 ASP H 54 ARG H 58 ILE H 51 ILE H 34	1.38A	20.60	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_C_NOVC2000_1 (DNA GYRASE SUBUNIT B)	6w41	CR3022 FAB HEAVY CHAIN (Homo sapiens)	5 / 12	GLU H 56 ASP H 54 ARG H 58 ILE H 51 ILE H 34	1.42A	20.60	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_1 (DNA GYRASE SUBUNIT B)	6w41	CR3022 FAB HEAVY CHAIN (Homo sapiens)	5 / 12	GLU H 56 ASP H 54 ARG H 58 ILE H 51 ILE H 34	1.51A	16.15	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1S14_B_NOVB2300_1 (TOPOISOMERASE IV SUBUNIT B)	6w41	CR3022 FAB HEAVY CHAIN (Homo sapiens)	5 / 12	SER H 55 ASP H 54 ARG H 58 ALA H 93 ILE H 34	1.78A	20.92	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_A_NOVA400_2 (DNA GYRASE SUBUNIT B)	6w41	CR3022 FAB HEAVY CHAIN CR3022 FAB LIGHT CHAIN (Homo sapiens)	3 / 3	ASN L 137 PHE L 118 VAL H 181	1.17A	20.12	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_B_NOVB2000_1 (DNA GYRASE SUBUNIT B)	6w41	CR3022 FAB HEAVY CHAIN (Homo sapiens)	5 / 12	GLU H 56 ASP H 54 ARG H 58 ILE H 51 ILE H 34	1.42A	20.60	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_A_NOVA2000_1 (DNA GYRASE SUBUNIT B)	6yla	HEAVY CHAIN (Homo sapiens)	5 / 12	GLU H 57 ASP H 55 ARG H 59 ILE H 51 ILE H 34	1.47A	20.46	MLI E 908 ( 4.4A) MLI E 908 (-3.9A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_1 (DNA GYRASE SUBUNIT B)	6yla	HEAVY CHAIN (Homo sapiens)	5 / 12	GLU B 57 ASP B 55 ARG B 59 ILE B 51 ILE B 34	1.53A	19.29	MLI B 302 (-4.4A) MLI B 302 ( 4.1A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_A_NOVA400_1 (DNA GYRASE SUBUNIT B)	6yla	HEAVY CHAIN (Homo sapiens)	5 / 12	GLU B 57 ASP B 55 ARG B 59 ILE B 51 ILE B 34	1.56A	19.29	MLI B 302 (-4.4A) MLI B 302 ( 4.1A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_A_NOVA400_1 (DNA GYRASE SUBUNIT B)	6yla	HEAVY CHAIN (Homo sapiens)	5 / 12	GLU H 57 ASP H 55 ARG H 59 ILE H 51 ILE H 34	1.60A	19.29	MLI E 908 ( 4.4A) MLI E 908 (-3.9A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_D_NOVD2000_1 (DNA GYRASE SUBUNIT B)	6yla	HEAVY CHAIN (Homo sapiens)	5 / 12	GLU H 57 ASP H 55 ARG H 59 ILE H 51 ILE H 34	1.56A	20.46	MLI E 908 ( 4.4A) MLI E 908 (-3.9A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_D_NOVD2000_1 (DNA GYRASE SUBUNIT B)	6yla	HEAVY CHAIN (Homo sapiens)	5 / 12	GLU B 57 ASP B 55 ARG B 59 ILE B 51 ILE B 34	1.52A	20.46	MLI B 302 (-4.4A) MLI B 302 ( 4.1A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_B_NOVB2000_1 (DNA GYRASE SUBUNIT B)	6yla	HEAVY CHAIN (Homo sapiens)	5 / 12	GLU H 57 ASP H 55 ARG H 59 ILE H 51 ILE H 34	1.52A	20.46	MLI E 908 ( 4.4A) MLI E 908 (-3.9A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_C_NOVC2000_1 (DNA GYRASE SUBUNIT B)	6yla	HEAVY CHAIN (Homo sapiens)	5 / 12	GLU H 57 ASP H 55 ARG H 59 ILE H 51 ILE H 34	1.52A	20.46	MLI E 908 ( 4.4A) MLI E 908 (-3.9A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_1 (DNA GYRASE SUBUNIT B)	6yla	HEAVY CHAIN (Homo sapiens)	5 / 12	GLU H 57 ASP H 55 ARG H 59 ILE H 70 ALA H 79	1.76A	19.29	MLI E 908 ( 4.4A) MLI E 908 (-3.9A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1AJ6_A_NOVA1_1 (GYRASE)	6yla	HEAVY CHAIN (Homo sapiens)	5 / 9	GLU H 57 ASP H 55 ARG H 59 ILE H 51 ILE H 34	1.57A	24.19	MLI E 908 ( 4.4A) MLI E 908 (-3.9A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1AJ6_A_NOVA1_1 (GYRASE)	6yla	HEAVY CHAIN (Homo sapiens)	5 / 9	GLU B 57 ASP B 55 ARG B 59 ILE B 51 ILE B 34	1.52A	24.19	MLI B 302 (-4.4A) MLI B 302 ( 4.1A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_A_NOVA2000_1 (DNA GYRASE SUBUNIT B)	6yla	HEAVY CHAIN (Homo sapiens)	5 / 12	GLU B 57 ASP B 55 ARG B 59 ILE B 51 ILE B 34	1.44A	20.46	MLI B 302 (-4.4A) MLI B 302 ( 4.1A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_A_NOVA400_2 (DNA GYRASE SUBUNIT B)	6yla	HEAVY CHAIN LIGHT CHAIN (Homo sapiens)	3 / 3	ASN C 143 PHE C 124 VAL B 185	1.14A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_1 (DNA GYRASE SUBUNIT B)	6yla	LIGHT CHAIN (Homo sapiens)	5 / 12	GLU C 87 PRO C 65 ASP C 66 ILE C 81 TYR C 92	1.63A	18.27	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_B_NOVB2000_1 (DNA GYRASE SUBUNIT B)	6yla	HEAVY CHAIN (Homo sapiens)	5 / 12	GLU B 57 ASP B 55 ARG B 59 ILE B 51 ILE B 34	1.49A	20.46	MLI B 302 (-4.4A) MLI B 302 ( 4.1A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_C_NOVC2000_1 (DNA GYRASE SUBUNIT B)	6yla	HEAVY CHAIN (Homo sapiens)	5 / 12	GLU B 57 ASP B 55 ARG B 59 ILE B 51 ILE B 34	1.49A	20.46	MLI B 302 (-4.4A) MLI B 302 ( 4.1A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_A_NOVA400_2 (DNA GYRASE SUBUNIT B)	6yla	HEAVY CHAIN LIGHT CHAIN (Homo sapiens)	3 / 3	ASN L 143 PHE L 124 VAL H 185	1.17A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_1 (DNA GYRASE SUBUNIT B)	6yla	LIGHT CHAIN (Homo sapiens)	5 / 12	GLU L 87 PRO L 65 ASP L 66 ILE L 81 TYR L 92	1.66A	18.27	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_1 (DNA GYRASE SUBUNIT B)	6yla	HEAVY CHAIN (Homo sapiens)	5 / 12	GLU H 57 ASP H 55 ARG H 59 ILE H 51 ILE H 34	1.59A	19.29	MLI E 908 ( 4.4A) MLI E 908 (-3.9A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_B_NOVB2000_1 (DNA GYRASE SUBUNIT B)	6ym0	HEAVY CHAIN (Homo sapiens)	5 / 12	GLU H 57 ASP H 55 ARG H 59 ILE H 51 ILE H 34	1.42A	21.40	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_C_NOVC2000_1 (DNA GYRASE SUBUNIT B)	6ym0	HEAVY CHAIN (Homo sapiens)	5 / 12	GLU H 57 ASP H 55 ARG H 59 ILE H 51 ILE H 34	1.43A	21.40	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_A_NOVA2000_1 (DNA GYRASE SUBUNIT B)	6ym0	HEAVY CHAIN (Homo sapiens)	5 / 12	GLU H 57 ASP H 55 ARG H 59 ILE H 51 ILE H 34	1.38A	21.40	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1AJ6_A_NOVA1_1 (GYRASE)	6ym0	HEAVY CHAIN (Homo sapiens)	5 / 9	GLU H 57 ASP H 55 ARG H 59 ILE H 51 ILE H 34	1.46A	24.29	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_A_NOVA400_1 (DNA GYRASE SUBUNIT B)	6ym0	HEAVY CHAIN (Homo sapiens)	5 / 12	GLU H 57 ASP H 55 ARG H 59 ILE H 51 ILE H 34	1.47A	19.29	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_D_NOVD2000_1 (DNA GYRASE SUBUNIT B)	6ym0	HEAVY CHAIN (Homo sapiens)	5 / 12	GLU H 57 ASP H 55 ARG H 59 ILE H 51 ILE H 34	1.45A	21.40	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_1 (DNA GYRASE SUBUNIT B)	6ym0	HEAVY CHAIN (Homo sapiens)	5 / 12	GLU H 57 ASP H 55 ARG H 59 ILE H 51 ILE H 34	1.44A	19.29	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_A_NOVA400_2 (DNA GYRASE SUBUNIT B)	6ym0	HEAVY CHAIN LIGHT CHAIN (Homo sapiens)	3 / 3	ASN L 143 PHE L 124 VAL H 185	1.15A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_B_NOVB2000_1 (DNA GYRASE SUBUNIT B)	6yor	IGG H CHAIN (Homo sapiens)	5 / 12	GLU B 57 ASP B 55 ARG B 59 ILE B 51 ILE B 34	1.53A	20.46	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1AJ6_A_NOVA1_1 (GYRASE)	6yor	IGG H CHAIN (Homo sapiens)	5 / 9	GLU H 57 ASP H 55 ARG H 59 ILE H 51 ILE H 34	1.57A	24.19	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_C_NOVC2000_1 (DNA GYRASE SUBUNIT B)	6yor	IGG H CHAIN (Homo sapiens)	5 / 12	GLU B 57 ASP B 55 ARG B 59 ILE B 51 ILE B 34	1.54A	20.46	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_D_NOVD2000_1 (DNA GYRASE SUBUNIT B)	6yor	IGG H CHAIN (Homo sapiens)	5 / 12	GLU H 57 ASP H 55 ARG H 59 ILE H 51 ILE H 34	1.57A	20.46	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_1 (DNA GYRASE SUBUNIT B)	6yor	IGG L CHAIN (Homo sapiens)	5 / 12	GLU C 87 PRO C 65 ASP C 66 ILE C 81 TYR C 92	1.65A	18.27	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_B_NOVB2000_1 (DNA GYRASE SUBUNIT B)	6yor	IGG H CHAIN (Homo sapiens)	5 / 12	GLU H 57 ASP H 55 ARG H 59 ILE H 51 ILE H 34	1.53A	20.46	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_1 (DNA GYRASE SUBUNIT B)	6yor	IGG H CHAIN (Homo sapiens)	5 / 12	GLU H 57 ASP H 55 ARG H 59 ILE H 70 ALA H 79	1.76A	19.29	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_1 (DNA GYRASE SUBUNIT B)	6yor	IGG L CHAIN (Homo sapiens)	5 / 12	GLU L 87 PRO L 65 ASP L 66 ILE L 81 TYR L 92	1.66A	18.27	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_A_NOVA400_2 (DNA GYRASE SUBUNIT B)	6yor	IGG H CHAIN IGG L CHAIN (Homo sapiens)	3 / 3	ASN L 143 PHE L 124 VAL H 185	1.18A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_A_NOVA2000_1 (DNA GYRASE SUBUNIT B)	6yor	IGG H CHAIN (Homo sapiens)	5 / 12	GLU H 57 ASP H 55 ARG H 59 ILE H 51 ILE H 34	1.48A	20.46	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1AJ6_A_NOVA1_1 (GYRASE)	6yor	IGG H CHAIN (Homo sapiens)	5 / 9	GLU B 57 ASP B 55 ARG B 59 ILE B 51 ILE B 34	1.58A	24.19	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_1 (DNA GYRASE SUBUNIT B)	6yor	IGG H CHAIN (Homo sapiens)	5 / 12	GLU B 57 ASP B 55 ARG B 59 ILE B 51 ILE B 34	1.60A	19.29	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_A_NOVA400_1 (DNA GYRASE SUBUNIT B)	6yor	IGG H CHAIN (Homo sapiens)	5 / 12	GLU H 57 ASP H 55 ARG H 59 ILE H 51 ILE H 34	1.61A	19.29	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_A_NOVA2000_1 (DNA GYRASE SUBUNIT B)	6yor	IGG H CHAIN (Homo sapiens)	5 / 12	GLU B 57 ASP B 55 ARG B 59 ILE B 51 ILE B 34	1.48A	20.46	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_A_NOVA400_2 (DNA GYRASE SUBUNIT B)	6yor	IGG H CHAIN IGG L CHAIN (Homo sapiens)	3 / 3	ASN C 143 PHE C 124 VAL B 185	1.17A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_A_NOVA400_1 (DNA GYRASE SUBUNIT B)	6yor	IGG H CHAIN (Homo sapiens)	5 / 12	GLU B 57 ASP B 55 ARG B 59 ILE B 51 ILE B 34	1.61A	19.29	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_1 (DNA GYRASE SUBUNIT B)	6yor	IGG H CHAIN (Homo sapiens)	5 / 12	GLU B 57 ASP B 55 ARG B 59 ILE B 70 ALA B 79	1.77A	19.29	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_C_NOVC2000_1 (DNA GYRASE SUBUNIT B)	6yor	IGG H CHAIN (Homo sapiens)	5 / 12	GLU H 57 ASP H 55 ARG H 59 ILE H 51 ILE H 34	1.53A	20.46	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_1 (DNA GYRASE SUBUNIT B)	6yor	IGG H CHAIN (Homo sapiens)	5 / 12	GLU H 57 ASP H 55 ARG H 59 ILE H 51 ILE H 34	1.59A	19.29	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_D_NOVD2000_1 (DNA GYRASE SUBUNIT B)	6yor	IGG H CHAIN (Homo sapiens)	5 / 12	GLU B 57 ASP B 55 ARG B 59 ILE B 51 ILE B 34	1.58A	20.46	None